{
  "$schema": "folio-library-entry/v1",
  "id": "10665-66977",
  "blocks": [
    {
      "id": "library/10665-66977/blocks/prose-sec-000",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Introducing hepatitis B vaccine into national immunization services",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/sec-000-introducing-hepatitis-b-vaccine-into-national-im.md",
      "narrative": null,
      "content": "",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "empty"
      }
    },
    {
      "id": "library/10665-66977/blocks/prose-sec-001",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "Hepatitis B immunization",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/sec-001-hepatitis-b-immunization.md",
      "narrative": null,
      "content": "Background\nHepatitis B (HepB) is a major public\nhealth problem worldwide.\nApproximately 30% of the world's\npopulation, or about 1.8 billion\npersons, have serologic evidence of\nhepatitis B virus (HBV) infection.  Of\nthese, an estimated 350 million have\nchronic HBV infection and at least\n500 000 chronically infected persons\ndie each year from liver cancer and\ncirrhosis.  HBV is second only to\ntobacco as a known human\ncarcinogen.\nA safe and effective vaccine against\nHBV infection has been available\nfor nearly 20 years.  HepB vaccine is\neffective in preventing HBV infections\nwhen it is given eithe",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The opening of the English edition of the WHO note on hepatitis B immunization, giving the burden of hepatitis B, with about 350 million chronic infections, and stating that a safe vaccine can prevent most related deaths. It explains that the aim of vaccination is to prevent chronic infection and reduce the reservoir for new infections.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-66977/blocks/prose-sec-002",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "DEPARTMENT OF VACCINES AND BIOLOGICALS",
      "pageStart": 1,
      "pageEnd": 1,
      "target": "../sections/sec-002-department-of-vaccines-and-biologicals.md",
      "narrative": null,
      "content": "AND BIOLOGICALS",
      "truncated": false,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "A fragment of the WHO Department of Vaccines and Biologicals heading.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    },
    {
      "id": "library/10665-66977/blocks/prose-sec-003",
      "types": [
        "folio-assistant-core:Prose",
        "doco:Section"
      ],
      "kind": "prose",
      "title": "World Health Organization 1211 Geneva 27",
      "pageStart": 1,
      "pageEnd": 4,
      "target": "../sections/sec-003-world-health-organization-1211-geneva-27.md",
      "narrative": null,
      "content": "1211 Geneva 27\n2001\nImmunization strategies\né\u0002\u0003\u0004\u0005\u0006\u00072\u0005\u0006\tù\u0006\u00042\u0005\n\n\u0003\u0006\u0005\nù\u0004\u0005\u0002\u0006F\nHepB immunization of all infants as\nan integral part of the national\nimmunization schedule should be the\nhighest priority in all countries.\nAdditional immunization strategies that\nshould be considered depending on the\nepidemiology of HBV transmission in a\nparticular country are:\n\u0001\nÇ\u0003\u0004\u0005\u0004\u0006\u0007\b\t\u00062\t\n2\n\u0004\u0003\b\u0006ù\u0007ù\u000e2rfå\n\u0007\u0003ù\u0006\u0012\u0013\b\u0012\u0012\b\t\u0006. In order to prevent\nHBV transmission from mother to\ninfant, the first dose of HepB vaccine\nneeds to be given as soon as possible\nafter birth (preferably within\n24 hours).  In countries where a high\npropo",
      "truncated": true,
      "provenance": "ingested",
      "summary": {
        "status": "draft",
        "text": "The main text of the English WHO note on hepatitis B immunization, setting routine infant vaccination as the top priority and recommending a birth dose within 24 hours where perinatal infection is common. It covers catch-up vaccination, monovalent versus combination formulations and three schedule options aligned with DTP doses. It also describes injection practice, equipment, cold chain, storage volumes, documents, training and budgeting. Some characters in the extracted text are garbled.",
        "state": "draft",
        "draftedBy": {
          "kind": "agent",
          "id": "claude-code",
          "model": "not-disclosed"
        },
        "draftedAt": "2026-11-11"
      }
    }
  ]
}
